Related Experiment Video
Updated: Mar 19, 2026

Small-Scale Plasma Membrane Preparation for the Analysis of Candida albicans Cdr1-mGFPHis
Published on: June 13, 2021
The Zinc Finger Protein Mig1 Regulates Mitochondrial Function and Azole Drug Susceptibility in the Pathogenic Fungus
Mélissa Caza1, Guanggan Hu1, Michael Price2
1Department of Microbiology and Immunology, Michael Smith Laboratories, University of British Columbia, Vancouver, Canada.
Abstract:
The opportunistic pathogen Cryptococcus neoformans causes fungal meningoencephalitis in immunocompromised individuals. In previous studies, we found that the Hap complex in this pathogen represses genes encoding mitochondrial respiratory functions and tricarboxylic acid (TCA) cycle components under low-iron conditions. The orthologous Hap2/3/4/5 complex in Saccharomyces cerevisiae exerts a regulatory influence on mitochondrial functions, and Hap4 is subject to glucose repression via the carbon catabolite repressor Mig1. In this study, we explored the regulatory link between a candidate ortholog of the Mig1 protein and the HapX component of the Hap complex in C. neoformans. This analysis revealed repression of MIG1 by HapX and activation of HAPX by Mig1 under low-iron conditions and Mig1 regulation of mitochondrial functions, including respiration, tolerance for reactive oxygen species, and expression of genes for iron consumption and iron acquisition functions. Consistently with these regulatory functions, a mig1Δ mutant had impaired growth on inhibitors of mitochondrial respiration and inducers of ROS. Furthermore, deletion of MIG1 provoked a dysregulation in nutrient sensing via the TOR pathway and impacted the pathway for cell wall remodeling. Importantly, loss of Mig1 increased susceptibility to fluconazole, thus further establishing a link between azole antifungal drugs and mitochondrial function. Mig1 and HapX were also required together for survival in macrophages, but Mig1 alone had a minimal impact on virulence in mice. Overall, these studies provide novel insights into a HapX/Mig1 regulatory network and reinforce an association between mitochondrial dysfunction and drug susceptibility that may provide new targets for the development of antifungal drugs. IMPORTANCE Fungal pathogens of humans are difficult to treat, and there is a pressing need to identify new targets for antifungal drugs and to obtain a detailed understanding of fungal proliferation in vertebrate hosts. In this study, we examined the roles of the regulatory proteins Mig1 and HapX in mitochondrial function and antifungal drug susceptibility in the fungus Cryptococcus neoformans. This pathogen is a particular threat to the large population of individuals infected with human immunodeficiency virus (HIV). Our analysis revealed regulatory interactions between Mig1 and HapX, and a role for Mig1 in mitochondrial functions, including respiration, tolerance for reactive oxygen species, and expression of genes for iron consumption and iron acquisition functions. Importantly, loss of Mig1 increased susceptibility to the antifungal drug fluconazole, which is commonly used to treat cryptococcal disease. These studies highlight an association between mitochondrial dysfunction and drug susceptibility that may provide new targets for the development of antifungal drugs.
Insights
The HapX/Mig1 regulatory network in Cryptococcus neoformans controls mitochondrial function and iron metabolism. Loss of Mig1 increases susceptibility to fluconazole, linking mitochondrial dysfunction to antifungal drug efficacy.
Area of Science:
- Mycology
- Molecular Biology
- Medical Microbiology
Background:
- Cryptococcus neoformans is an opportunistic fungal pathogen causing meningoencephalitis in immunocompromised individuals.
- The Hap complex regulates mitochondrial respiration and TCA cycle genes under low-iron conditions.
- Mig1 in Saccharomyces cerevisiae is involved in glucose repression and mitochondrial regulation.
Purpose of the Study:
- To investigate the regulatory relationship between Mig1 and HapX in C. neoformans.
- To elucidate the role of Mig1 in mitochondrial function and antifungal drug susceptibility.
- To identify novel therapeutic targets for fungal infections.
Main Methods:
- Analysis of regulatory interactions between HapX and Mig1.
- Gene deletion studies (mig1Δ mutant) to assess phenotypic changes.
- Assessment of mitochondrial functions, including respiration and reactive oxygen species (ROS) tolerance.
- Evaluation of drug susceptibility and virulence in a murine model.
Main Results:
- HapX represses MIG1, while Mig1 activates HAPX under low-iron conditions.
- Mig1 regulates mitochondrial respiration, ROS tolerance, and iron acquisition gene expression.
- mig1Δ mutants exhibit impaired growth, dysregulated nutrient sensing (TOR pathway), and increased susceptibility to fluconazole.
- Mig1 and HapX are essential for survival in macrophages; Mig1 has minimal impact on mouse virulence.
Conclusions:
- A novel HapX/Mig1 regulatory network controlling mitochondrial function and iron metabolism in C. neoformans has been identified.
- Mitochondrial dysfunction is linked to increased susceptibility to azole antifungal drugs like fluconazole.
- This network represents a potential target for developing new antifungal therapies.
Related Concept Videos
Fungal Group Zygomycota
Antifungal Agents
Fungal Phylum Microsporidia

